Breaking Down Chengdu Guibao Science & Technology Co.,Ltd. Financial Health: Key Insights for Investors

Dive into a data-driven dissection of Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ): from a robust top-line that reached CNY 3.16 billion in 2024 and CNY 2.651 billion for the first three quarters of 2025 (up 24.30% YoY) - outpacing the specialty chemicals industry's 17.3% growth - to margins and profitability that tell a more nuanced story, with net profit attributable to shareholders at CNY 237.53 million in 2024 (a 24.63% decline) and EPS of CNY 0.61, while gross profit margin held at 20.8% and ROE was 9.3%; balance-sheet strengths include cash and equivalents of CNY 932.2 million, total debt of CNY 251.7 million as of September 2025 and a debt-to-equity ratio cut from 33.7% to 10.9% over five years, supported by operating cash flow of CNY 483.8 million (free cash flow CNY 314.84 million) and liquidity metrics like a current ratio of 2.07 and quick ratio of 1.51, and investors should weigh valuation signals - trailing P/E 30.31, forward P/E 27.99, EV/EBITDA 21.76, P/S 2.53, P/B 3.48, market cap CNY 9.32 billion and a low beta of 0.29 - against risks such as raw material price volatility, rising environmental compliance costs and exposure to China's property market, plus upside levers including expansion to 4,000 tpa silicon-carbon anode capacity and demand from solar and infrastructure sectors.

Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ) Revenue Analysis

• Operating revenue (Jan-Sep 2025): CNY 2.651 billion, up 24.30% year-on-year.
• Full-year revenue (2024): CNY 3.160 billion, up 21.24% from CNY 2.610 billion in 2023.
• 2024 growth vs. industry: Company growth (21.24%) outpaced the specialty chemicals industry average (17.3%).
• Primary growth drivers: increased demand in construction and automotive sectors; diversified product portfolio helped capture cross-sector opportunities.
• Context: Revenue expansion occurred despite ongoing global supply-chain challenges during 2024-2025.

• Segment contributions: construction and automotive led volume and pricing improvement; specialty formulations and additives broadened addressable markets.
• Operational resilience: diversified product lines and customer base offset supply-chain headwinds, sustaining revenue gains.
• Investor implication: revenue trajectory indicates above-industry growth, with 2025 YTD figures suggesting continued expansion if end-market demand holds.

Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ) Profitability Metrics

Key profitability indicators for Chengdu Guibao Science & Technology Co.,Ltd. show a meaningful contraction in 2024 driven by input cost pressures and higher operating expenses. Relevant historical context and corporate background can be found here: Chengdu Guibao Science & Technology Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

• Net profit attributable to shareholders (2024): CNY 237.53 million (down 24.63% vs. 2023)
• Net profit margin (2024): ~7.5% - evidence of competitive pressure in specialty chemicals
• Return on equity (ROE, 2024): 9.3% - indicates continued, though reduced, efficiency in using shareholders' equity
• Earnings per share (EPS, 2024): CNY 0.61 (down 24.7% vs. 2023)
• Gross profit margin (2024): 20.8% - signals effective cost control despite margin compression

• Primary drivers of 2024 decline:
  • Elevated raw material costs reducing gross and net margins
  • Higher operating expenses compressing operating profit
  • Competitive pricing pressure within the specialty chemicals segment
• Positive signal: gross profit margin of 20.8% demonstrates maintained cost management measures despite top-line pressure.

Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ) - Debt vs. Equity Structure

• Deleveraging: Debt-to-equity fell from 33.7% to 10.9% over five years, reflecting a deliberate reduction in leverage.
• Liquidity buffer: Cash (CNY 932.2m) comfortably exceeds outstanding debt, providing flexibility for operations and investments.
• Coverage strength: Interest coverage of 36.42 signals negligible near-term interest-payment risk.
• Short-term solvency: A current ratio of 2.07 indicates sufficient short-term assets to meet liabilities.
• Cash-backed debt: Operating cash flow at 238.6% of total debt (~CNY 600.7m) means operating cash generation more than covers outstanding debt.

Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ) Liquidity and Solvency

• Operating cash flow (2024): CNY 483.8 million - materially higher than reported net income, signaling high quality of earnings.
• Free cash flow (2024): CNY 314.84 million - up 27.7% year-over-year, reflecting improving cash conversion and operational efficiency.
• Cash reserves: CNY 932 million - a sizeable liquidity buffer supporting working capital and strategic flexibility.
• Quick ratio: 1.51 - indicates adequate immediate liquidity to cover current liabilities without relying on inventory sales.
• Net cash position: CNY 932 million (net of debt) - enhances financial flexibility and reduces solvency risk.
• Capital expenditures (2024): CNY 168.96 million - comfortably funded from operating cash flow, with OCF covering CapEx multiple-times over.

Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ) - Valuation Analysis

• Trailing P/E: 30.31 - market pays ~30.3x last 12 months' earnings.
• Forward P/E: 27.99 - implied earnings multiple based on analyst estimates.
• EV/EBITDA: 21.76 - valuation of operating cash profitability before non-cash charges.
• P/S: 2.53 - company valued at ~2.5x annual sales.
• P/B: 3.48 - market values net assets at ~3.5x book value.
• Market Capitalization: CNY 9.32 billion; Enterprise Value: CNY 8.71 billion.
• Beta: 0.29 - significantly lower historical volatility versus the broader market.

Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ) - Risk Factors

• Raw material price volatility: feedstock and petrochemical derivatives are the largest input cost. A sustained 10-15% rise in input prices historically compresses gross margin by ~2-4 percentage points and EBITDA margin by ~2-3 p.p.
• Environmental compliance costs: reported environmental & safety-related operating costs rose ~40% year-on-year to roughly RMB 85 million in the most recent fiscal period, and capitalized environmental capex was ~RMB 120 million.
• Property-market exposure: an estimated ~25% of product volumes are sold into construction and infrastructure-related end markets, making revenue and volume growth sensitive to Chinese property sector dynamics.
• Industry competition: the specialty chemicals market is fragmented and competitive; market-share pressure contributes to price sensitivity and margin compression.
• Regulatory change risk: anticipated tighter emission and waste-disposal standards could require incremental CAPEX of RMB 200-300 million over 2-3 years for compliance and process upgrades.
• Domestic concentration: over 85% of sales are domestic, leaving the company exposed to Chinese macro and policy cycles rather than diversified geographic demand.

• Raw material shocks: monitor feedstock price indices and gross-margin trends; a persistent 15% input cost spike could reduce annual net profit by ~RMB 60-90 million at current volumes.
• Capex timing vs. cash flow: large compliance investments (RMB 200-300m) may require financing or reduce free cash flow for shareholder returns in the next 2-3 years.
• Revenue cyclicality from property: a deepening property downturn could reduce overall volumes by 10-20% in a severe scenario, translating to comparable revenue declines absent offsetting demand in other sectors.
• Competitive pricing pressure: new entrants or capacity additions in specialty segments can force price concessions, lowering realizations and compressing margins.
• Policy/regulatory surprise: faster-than-expected tightening of emissions or waste rules would accelerate CAPEX and operating cost increases beyond current guidance.
• Concentration risk: reliance on the Chinese market amplifies sensitivity to domestic policy and macro swings; diversification would reduce single-market exposure.

• Gross margin trends quarter-over-quarter and absolute feedstock cost per tonne.
• Quarterly environmental opex and disclosed CAPEX plans or regulatory notices.
• Order book and sales mix shifts away from construction into more resilient end markets.
• Receivables days and working capital movements if margins compress and cash conversion weakens.
• Announcements on capacity expansions by competitors or price concessions in key product lines.

Chengdu Guibao Science & Technology Co.,Ltd. (300019.SZ) - Growth Opportunities

• Silicon‑carbon anode capacity scale-up - production capacity targeted at 4,000 tons per year, enabling volume contracts with EV and energy-storage battery makers and improving per‑unit cost economics as utilization rises.
• Photovoltaic materials demand - rising deployment of PV systems in China and globally increases demand for upstream specialty materials and chemical inputs the company can supply or adapt for PV applications.
• Infrastructure-driven demand - large-scale Chinese infrastructure and construction initiatives create steady, diversified demand for construction‑adjacent materials and specialty additives.
• Application-specific solutions - focus on tailored formulations supports premium pricing, longer-term customer relationships, and differentiation versus commodity producers.
• R&D investment - ongoing product development expands addressable markets (battery anodes, PV materials, construction additives) and shortens time-to-market for higher-margin products.
• Balance sheet strength - a solid capital base and liquidity position (enabling capacity buildouts and R&D funding) positions the company to seize product, capacity, and M&A opportunities during market upcycles.